A new model for embryotoxicity testing: teratogenicity and pharmacokinetics of valproic acid following constant-rate administration in the mouse using human therapeutic drug and metabolite concentrations-Reference-Cited by-同舟云学术

A new model for embryotoxicity testing: teratogenicity and pharmacokinetics of valproic acid following constant-rate administration in the mouse using human therapeutic drug and metabolite concentrations

Published:1981-12 Issue:26 Volume:29 Page:2803-2813
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Nau H.,Zierer R.,Spielmann H.,Neubert D.,Gansau Ch.

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference19 articles.

1. Clinical Pharmacokinetics of Valproic Acid1

2. Valproic acid dosage and plasma protein binding and clearance

3. Epilepsy Pregnancy and the Child;Nau,1981

4. Proceedings of the Fourth International Conference on Stable Isotopes;Wittfoht,1981

Cited by 162 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Obstetrical Outcomes of Patients with Epilepsy in a Canadian Tertiary Care Center (2014–2020);Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques;2023-07-17

2. Quantitative in vitro to in vivo extrapolation for developmental toxicity potency of valproic acid analogues;Birth Defects Research;2022-05-09

3. The North American Antiepileptic Drug Pregnancy Registry: A Canadian Subgroup Analysis;Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques;2022-01-13

4. Modified Xenopus laevis approach (R-FETAX) as an alternative test for the evaluation of foetal valproate spectrum disorder;Reproductive Toxicology;2022-01

5. Chromatin Imbalance as the Vertex Between Fetal Valproate Syndrome and Chromatinopathies;Frontiers in Cell and Developmental Biology;2021-04-20